40
Views
0
CrossRef citations to date
0
Altmetric
Review

An approach to the diagnosis and management of acute bacterial rhinosinusitis

, &
Pages 271-278 | Published online: 10 Jan 2014

References

  • Woodwell DA, Cherry DK. National Ambulatory Medical Care Survey (NAMCS). Adv. Data 346, 1–44 (2004).
  • Ray NF, Baraniuk JN, Thamer M et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J. Allergy Clin. Immunol. 103, 408–414 (1999).
  • Physician Drug & Diagnosis Audit (PDDA) and Source Prescription Audit (SPA) from Verispan. Imed options LLC (2002).
  • Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol. Head Neck Surg. 117, S1–S7 (1997).
  • Agency for Health Care Policy and Research. Diagnosis and Treatment of Acute Bacterial Rhinosinusitis. AHCPR, Rockville, MD, USA (1999).
  • The Sinus and Allergy Health Partnership (SAHP). Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol. Head Neck Surg. 130(1), 1–45 (2004).
  • Gwaltney JM Jr. Acute community-acquired sinusitis. Clin. Infect. Dis. 23, 1209–1223 (1996).
  • LaCroix JS, Ricchetti A, Lew D et al. Symptoms and clinical and radiological signs predicting the presence of pathogenic bacteria in acute rhinosinusitis. Acta Otolaryngol. 122, 192–196 (2002).
  • Vinuya RZ. Upper airway disorders and asthma: a syndrome of airway inflammation. Ann. Allergy Asthma Immunol. 88(4 Suppl.1), 8–15 (2002).
  • Ramadan HH, Hinerman RA. Smoke exposure and outcome of endoscopic sinus surgery in children. Otolaryngol. Head Neck Surg. 127(6), 546–548 (2002).
  • Gwaltney JM Jr, Phillips CD, Miller RD et al. Computed tomographic study of the common cold. N. Engl. J. Med. 330, 25–30 (1994).
  • Benninger MS, Holzer SE, Lau J. Diagnosis and treatment of uncomplicated acute bacterial rhinosinusitis: summary of the agency on Health Care Policy and Research evidence-based report. Otolaryngol. Head Neck Surg. 122, 1–7 (2000).
  • Marchant C, Carlin S, Johnson C et al. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the “Pollyanna phenomenon.” J. Pediatr. 120, 72–77 (1992).
  • Kays MB, Smith DW, Wack MF et al. Levofloxacin treatment failure in a patient with a fluoroquinolone-resistant Streptococcus pneumoniae pneumonia. Pharmacotherapy 22, 395–399 (2002).
  • Kuehnert MJ, Nolte FS, Perlino CA. Fluoroquinolone resistance in Streptococcus pneumoniae. Ann. Intern. Med. 131, 312–313 (1999).
  • Dagan R, Leibovitz E, Fliss DM et al. Bacteriologic efficacies of oral azithromycin and oral ceclor in treatment of acute otitis media in infants and young children. Antimicrob. Agents Chemother. 44, 43–50 (2000).
  • Ferguson BJ, Guzzeta RV, Spector SL, Hadley JA. Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis. Otolaryngol. Head Neck Surg. 131(3), 207–214 (2004).
  • Inanli S, Ozturk O, Korkmaz M, Tutkun A, Batman C. The effects of topical agents of fluticasone propionate, oxymetazoline, and 3% and 0.9% sodium chloride solutions on mucociliary clearance in the therapy of acute bacterial rhinosinusitis in vivo. Laryngoscope 112(2), 320–325 (2002).
  • Vaughn WC, Carvalho G. Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolarygol. Head Neck Surg. 127(6), 558–568 (2002).
  • Scheinberg PA, Otsuji A. Nebulized antibiotics for the treatment of acute exacerbations of chronic rhinosinusitis. ENT Journal 81(9), 648–652 (2002).
  • Thaler ER, Bruny FC, Kennedy DW, Hanson CW. Use of an electronic nose to distinguish cerebrospinal fluid from serum. Arch. Otolaryngol. Head Neck Surg. 126, 71–74 (2000).
  • Shykhon ME, Morgan DW, Dutta R, Hines EL, Gardner JW. Clinical evaluation of the electronic nose in the diagnosis of ear, nose and throat infection: a preliminary study. J. Laryngol. Otol. 118(9), 706–709 (2004).
  • Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN and the Alexander Project Group. The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J. Antimicrob. Chemother. 52, 229–246 (2003).
  • Jones RN, Johnson DM, Sader HS, Fritsche TR. Recent declines in b-lactam and MLSB resistance among S. pneumoniae and age-related effects: report from the SENTRY Antimicrobial Surveillance Program. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois, USA 14–17 September 2003 (Presentation C2–926).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.